Skip to main content
SpringerLink
Log in

Antineoplastics

Development of resistance to endocrine therapy and trastuzumab: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Spranklin L, et al. Discordance of receptor status in breast cancer throughout tumor progression and the associated prognostic implications: A case report and review of the literature. Cancer Treatment Communications 5: 36-38, Dec 2016. Available from: URL: http://doi.org/10.1016/j.ctrc.2015.12.001 - USA

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastics. Reactions Weekly 1652, 37 (2017). https://doi.org/10.1007/s40278-017-30174-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-30174-3

Search

Navigation